DRG Epidemiology's coverage of diabetic nephropathy comprises epidemiological estimates of key patient populations across 14 mature and emerging pharmaceutical markets worldwide. We report the prevalence of diabetic nephropathy for each country, as well as annualized case counts projected to the national population.

Most patient populations are forecasted over a period of 20 years for the major mature pharmaceutical markets of the United States, Europe, and Japan and 10 years for the other countries covered in this report.

DRG Epidemiology's diabetic nephropathy forecast will answer the following questions:

  • Of all people with diabetic nephropathy, how many in each country across the major mature pharmaceutical markets have been formally diagnosed?
  • Of all people diagnosed with diabetic nephropathy, how many in each country across the major mature pharmaceutical markets are drug-treated?
  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of diabetic nephropathy over the forecast period?

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

DRG Epidemiology provides at least ten years of forecast data for the following diabetic nephropathy patient populations:

  • Total prevalent cases of diabetic nephropathy.
  • Total prevalent cases of diabetic nephropathy by severity.
  • Diagnosed prevalent cases of diabetic nephropathy.
  • Drug-treated prevalent cases of diabetic nephropathy.

Note: Coverage may vary by country and region.

Table of contents

  • Diabetic Nephropathy - Epidemiology - Emerging Markets Data

Author(s): Joseph Granato, MPH

Joseph Granato joined Decision Resources Group in 2012 and previously worked on both Market Access and Global Market Access products.  Joseph is currently responsible for forecasting the prevalence and incidence of disease populations throughout the world.  He is also tasked with identifying at risk populations and developing new epidemiological methods used to predict overall population health.

He received his M.P.H. from Des Moines University where he worked on several population health projects including the delivery of continuing medical education on tick-borne diseases.  He also holds a B.S. in Animal Science from the University of Tennessee.  Prior to his time with DRG Joseph worked with the Monroe County Health Department on the surveillance of reportable diseases including Dengue Fever.


Related Reports

Diabetic Nephropathy - Landscape & Forecast - Disease Landscape & Forecast

Diabetic nephropathy (DN), also referred to as diabetic kidney disease, is a common complication of diabetes. Current standard of care fails to halt the fr...

View Details

Diabetic Nephropathy - Current Treatment - Detailed, Expanded Analysis - Treatment Algorithms - Claims Data Analysis (US)

Diabetic nephropathy, also referred to as diabetic kidney disease, is a common complication of diabetes. The diabetic nephropathy drug market comprises a wide variety of antidiabetic and antihypert...

View Details

Diabetic Nephropathy | Disease Landscape and Forecast | G7 | 2019

Diabetic nephropathy (DN), also referred to as diabetic kidney disease, is a common complication of diabetes. Current standard of care fails to halt the fr...

View Details